Ergoteles LLC Catalent, Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $826,309 - $1.62 Million	19,964 New	19,964 $898,000
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $3.11 Million - $4.07 Million	35,686 New	35,686 $3.83 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $627,264 - $729,561	-5,246 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $189,082 - $246,550	1,732 Added 49.29%	5,246 $698,000
Q2 2021 Aug 12, 2021	BUY	$100.34 - $115.69 $352,594 - $406,534	3,514 New	3,514 $380,000
Q1 2021 May 12, 2021	SELL	$101.51 - $125.27 $972,364 - $1.2 Million	-9,579 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$85.88 - $105.36 $822,644 - $1.01 Million	9,579 New	9,579 $997,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.